Sign Up
Stories
Biotech Advancements in Cancer Treatment
Share
Biotech Firms Advance Cancer Treatment
Eli Lilly's Cancer Therapy Acquisition
Faron Pharmaceuticals: Clinical Updates ...
12 Million Euros for Cancer Research
AI-Powered Antigen Research Partnership
Adcetris Boosts Lymphoma Patients' Survi...
Overview
API
Biotechnology companies Anixa Biosciences, Genelux Corporation, ALX Oncology, IN8bio, and CancerVAX, Inc. are making significant strides in the cancer treatment and prevention field. Anixa Biosciences establishes a Cancer Business Advisory Board, Genelux Corporation presents at an investment conference, ALX Oncology reorganizes its leadership, IN8bio participates in a conference, and CancerVAX, Inc. discusses cancer immunotherapy in a podcast.
Ask a question
How might the establishment of the Cancer Business Advisory Board influence Anixa Biosciences' clinical and business development initiatives?
How might the reorganization of ALX Oncology's executive leadership team impact the company's focus on developing therapies that block the CD47 immune checkpoint pathway?
What potential implications could the development of immunotherapies by Genelux Corporation have on the treatment of aggressive and difficult-to-treat solid tumors?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage